Skip to main content
. Author manuscript; available in PMC: 2023 Jan 12.
Published in final edited form as: Lancet Microbe. 2023 Jan;4(1):e38–e46. doi: 10.1016/S2666-5247(22)00296-8

Figure 1: Host response-based screen for undiagnosed infections (week 4, January, 2017).

Figure 1:

(A) The screening process for samples tested with the respiratory virus panel. True unknowns were negative for the ten viruses on the respiratory virus panel and parainfluenza virus 4 and four seasonal coronaviruses (not included in the respiratory virus panel). (B) Nasopharyngeal CXCL10 concentrations for virus PCR-negative samples, showing those selected for RNA sequencing (samples A–H) based on CXCL10 (>1 ng/mL) and sufficient RNA content. (C) Reads in sample A map to each of the seven gene segments of the influenza C virus genome.